ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)
China
· Delayed Price · Currency is CNY 42.61
-0.14 (-0.33%)
Mar 9, 2026, 4:00 PM EDT
ChengDa Pharmaceuticals Revenue
ChengDa Pharmaceuticals had revenue of 102.64M CNY in the quarter ending September 30, 2025, with 28.69% growth. This brings the company's revenue in the last twelve months to 374.46M, down -5.87% year-over-year. In the year 2024, ChengDa Pharmaceuticals had annual revenue of 333.13M, down -19.59%.
Revenue (ttm)
374.46M
Revenue Growth
-5.87%
P/S Ratio
17.24
Revenue / Employee
616.90K
Employees
656
Market Cap
6.45B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Beijing SL Pharmaceutical | 578.61M |
| Jinghua Pharmaceutical Group | 1.45B |
| Guizhou Xinbang Pharmaceutical | 5.73B |
| Tibet Duo Rui Pharmaceutical | 177.11M |
| Beijing Beilu Pharmaceutical | 1.13B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 1.17B |
| HPGC Renmintongtai Pharmaceutical | 10.22B |